je.st
news
Tag: highrisk
With 24/7, high-risk jobs, Jacksonville CEOs have been paid far above ...
2015-03-22 15:21:01| Railroads - Topix.net
Frank Martire, who is moving to Jacksonville as the new president and chief executive officer of FIS, Fidelity National Information. October 1, 2009.
Tags: jobs
far
paid
jacksonville
County gets new tools for high-risk fire season
2014-09-04 06:32:07| Energy - Topix.net
County officials are getting ready for the fall fire season, with help from some new equipment to help battle flames from above. For a fifth straight year, San Diego Gas & Electric has contracted for the use of a firefighting helitanker with the capacity to drop up to 2,500 gallons of water at a time.
Tags: tools
county
fire
season
SDG&E Air Assets Arrive For High-Risk Fire Season
2014-09-03 19:12:00| Transmission & Distribution World
As part of San Diego Gas & Electric's efforts to serve as a regional partner in public safety, the utility has contracted the Erikson Air-Crane helitanker for the fifth consecutive high-risk fire season. Content Classification: Curated read more
Wall Street warned $91 billion of high-risk oil megaprojects
2014-08-18 16:00:00| Climate Ark Climate Change & Global Warming Newsfeed
InsideClimate News: Critics of environmentally risky oil projects proposed for deep undersea and Canada's tar sands got new ammunition last week when a report labeled those ventures and others as the industry's most financially questionable pursuits. The new report, published by the Carbon Tracker Initiative (CTI), identifies a host of drawing-board oil projects that would cost a combined $91 billion over the next decade--and that would lose money if lower demand, carbon restrictions or other factors forced crude...
Merck Initiates Phase 3 Study of Letermovir, an Investigational Antiviral for Prevention of Cytomegalovirus (CMV) Infection in High-Risk Bone Marrow Transplant Patients
2014-07-24 14:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the first patient has been enrolled in a global Phase 3 clinical study of letermovir (MK-8228), an investigational antiviral agent. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558orRobert Consalvo, 908-423-6595orInvestor:Joseph Romanelli, 908-423-5185orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: study
phase
patients
prevention